Man

Nuria Eugenia Campillo Martín

Científico titular

Centro de Investigaciones Biológicas (CIB-CSIC)

Madrid, España

Líneas de Investigación


Medicinal chemistry, Drug Discovery, Drug Design, Cheminformatics, Bioinformatics. Molecular modelling, ligand-based design, receptor-based design, quantitative structure-activity relationships, ligand-receptor interactions, computational chemistry,

Educación

  •  Chemistry, UNIVERSIDAD AUTONOMA DE MADRID. España, 1992
  •  Chemistry, UNIVERSIDAD AUTONOMA INDOAMERICA. Chile, 1997

Premios y Distinciones

  •   Salvador de Madariaga scolarship

    Spanish Ministry of Education and Competitiveness

    España, 2017

    Awarded a Salvador de Madariaga scholarship from the Spanish Ministry of Education and Competitiveness for a short-term visiting professor stay at the University of Michigan (October 1st through December 31st, 2017. Host: Prof. John Montgomery).

  •   Salvador de Madariaga scolarship

    Spanish Ministry of Education and Competitiveness

    Chile, 2016

    Awarded a Salvador de Madariaga scholarship from the Spanish Ministry of Education and Competitiveness for a short-term visiting professor stay at the University of Cambridge (July 1st through September 31st, 2016. Host: Prof. Tom Blundell).

  •   Parque Científico de Madrid: AITENEA

    UNIVERSIDAD COMPLUTENSE DE MADRID

    Chile, 2019

    IX edición de los Premios Emprendedor Universitario UCM MODALIDAD III. PREMIOS A PROYECTOS EMPRESARIALES Programa Explorer UCM-Santander. Proyecto AITENEA Ganador Nacional Tecnología Disruptiva


 

Article (78)

Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational tools
Targeting Cannabinoid Receptor Activation and BACE-1 Activity Counteracts TgAPP Mice Memory Impairment and Alzheimer's Disease Lymphoblast Alterations
Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3
Computer-aided molecular design of pyrazolotriazines targeting glycogen synthase kinase 3
Discovery of novel Schistosoma mansoni PDE4A inhibitors as potential agents against schistosomiasis
Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease
Indazolylketones as new multitarget cannabinoid drugs
Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases
QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer's Disease
QSAR Modelling for Drug Discovery: Predicting the Activity of LRRK2 Inhibitors for Parkinson's Disease Using Cheminformatics Approaches
QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson's Disease
Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease
Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitors
Cyclic Nucleotide-Specific Phosphodiesterases as Potential Drug Targets for Anti-Leishmania Therapy
Deciphering the Inhibition of the Neuronal Calcium Sensor 1 and the Guanine Exchange Factor Ric8a with a Small Phenothiazine Molecule for the Rational Generation of Therapeutic Synapse Function Regulators
Identification of new allosteric sites and modulators of AChE through computational and experimental tools
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3 beta and Tau-Aggregation Inhibitors
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease
Hybridizing Feature Selection and Feature Learning Approaches in QSAR Modeling for Drug Discovery
Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome
Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents
Medicinal and Biological Chemistry (MBC) Library: An Efficient Source of New Hits
Novel Imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxides as antiproliferative trypanosoma cruzi drugs: Computational screening from neural network, synthesis and in vivo biological properties
Subtly Modulating Glycogen Synthase Kinase 3 beta: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases
New applications for known drugs: Human glycogen synthase kinase 3 inhibitors as modulators of Aspergillus fumigatus growth
From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer's Disease
Therapeutic approaches for the future treatment of Fragile X
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease
Mutagenicity of N-oxide Containing Heterocycles and Related Compounds: Experimental and Theoretical Studies
Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease
The value of selected in vitro and in silico methods to predict acute oral toxicity in a regulatory context: Results from the European Project ACuteTox
Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities
5-Imino-1,2,4-Thiadiazoles: First Small Molecules As Substrate Competitive Inhibitors of Glycogen Synthase Kinase 3
Amidines bearing benzofuroxan or benzimidazole 1,3-dioxide core scaffolds as Trypanosoma cruzi-inhibitors: structural basis for their interactions with cruzipain
Effect of Phosphodiesterase 7 (PDE7) Inhibitors in Experimental Autoimmune Encephalomyelitis Mice. Discovery of a New Chemically Diverse Family of Compounds
Identification in Silico and Experimental Validation of Novel Phosphodiesterase 7 Inhibitors with Efficacy in Experimental Autoimmune Encephalomyelitis Mice
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model
Dissimilar interaction of CB1/CB2 with lipid bilayers as revealed by molecular dynamics simulation
Exploring the Binding Sites of Glycogen Synthase Kinase 3. Identification and Characterization of Allosteric Modulation Cavities
Chagas Disease: Progress and New Perspectives
Cpl-7, a Lysozyme Encoded by a Pneumococcal Bacteriophage with a Novel Cell Wall-binding Motif
Development of second generation amidinohydrazones, thio- and semicarbazones as Trypanosoma cruzi-inhibitors bearing benzofuroxan and benzimidazole 1,3-dioxide core scaffolds
Neural computational prediction of oral drug absorption based on CODES 2D descriptors
p-Coumaric acid decarboxylase from Lactobacillus plantarum: Structural insights into the active site and decarboxylation catalytic mechanism
Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimer's Disease
Crystal structure of CbpF, a bifunctional choline-binding protein and autolysis regulator from Streptococcus pneumoniae
Crystal structure of CbpF, a bifunctional choline-binding protein and autolysis regulator from Streptococcus pneumoniae (vol 10, pg 246, 2009)
Interaction studies between human alpha-tocopherol transfer protein and nitric oxide donor tocopherol analogues with LDL-protective activity
Synthesis, Structural Analysis, and Biological Evaluation of Thioxoquinazoline Derivatives as Phosphodiesterase 7 Inhibitors
Tacrine-Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties
Artificial neural networks in ADMET modeling: Prediction of blood-brain barrier permeation
Design, synthesis, and evaluation of potential inhibitors of nitric oxide synthase
Docking, synthesis, and NMR studies of mannosyl trisaccharide ligands for DC-SIGN lectin
PDE7 inhibitors as new drugs for neurological and inflammatory disorders
Elucidation of the molecular recognition of bacterial cell wall by modular pneumococcal phage endolysin CPL-1
In vivo anti-chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivatives
The role of cofactor binding in tryptophan accessibility and conformational stability of His-tagged D-amino acid oxidase from Trigonopsis variabilis
The tautomerism of 5-amino-3-oxo-1,2,4-thiadiazole: An experimental and theoretical study
Directed mutagenesis alters the stereochemistry of catalysis by isolated ketoreductase domains from the erythromycin polyketide synthase
Glycopyrrolate combinations for the treatment of respiratory diseases
Homology modelling and active-site-mutagenesis study of the catalytic domain of the pneumococcal phosphorylcholine esterase
Homology models of the cannabinoid CB1 and CB2 receptors. A docking analysis study
Unravelling the structure of the pneumococcal autolytic lysozyme
A study of peculiar tautomerism of pyrido[2,3-c] [1,2,6]thiadiazine 2,2-dioxide system
Synthesis and nematocide activity of S-glycopyranosyl-6,7-diarylthioinmazines
Active-site-mutagenesis study of rat liver betaine-homocysteine S-methyltransferase
On the reactivity of 1H-pyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxide and derivatives: Nucleophilic substitution, amination, aldol-type condensation, oxidation, and hydrolysis
Plant-based heterologous expression of Mal d 2, a thaumatin-like protein and allergen of apple (Malus domestica), and its characterization as an antifungal protein
The origin of the serum resistance associated (SRA) gene and a model of the structure of the SRA polypeptide from Trypanosoma brucei rhodesiense
Novel bronchodilators in the treatment of asthma and COPD
Unconventional alkoxylation of pyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides mediated by N-halosuccinimides
Phosphoribosyltransferase superfamily: A comparative structural analysis
Novel bronchodilators: Synthesis, transamination reactions, and pharmacology of a series of pyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides
Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation
Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as platelet aggregation inhibitors. 2. Optimization by quantitative structure-activity relationships
Ring strain and hydrogen bond acidity
Solvent effect on the tautomerism of 4-aminopyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides

Patent (3)

Nueva Familia de Derivados Carbonílicos de 1-Indazolilo Con Propiedades Cannabinoides y/o Colinérgicas y/o Reguladoras Del Péptido Beta-Amiloide
Una nueva familia de éteres de 3-indazolilo con propiedades cannabinoides y/o colinérgicas.
Derivados de Indazol para el Tratamiento del Cancer Indazole Derivatives For Cancer Treatment

Proyecto (11)

Análisis científico, filosófico y social del covid19: repercusión social, implicaciones éticas y cultura de la prevención frente a las pandemias
Target- and ligand-based drugs to control SARS-CoV-2 pandemic
Combinación de estrategias computacionales, biológicas y sintéticas con aplicación al desarrollo de fármacos
Locking cell against Ebola virus
Development and long-term sustainability of new pan-European research infrastructures
Diseño y desarrollo de fármacos innovadores para la Esclerosis Lateral Amiotrófica
Red de Investigación Colaborativa en Enfermedades Tropicales RICET
Chemi-computation to discovery of multitarget drugs for the treatment of Alzheimer's disease
Desarrollo de farmacos innovadores para la enfermedad de Chagas
Nuevas Aproximaciones para el Descubrimiento y Desarrollo de Fármacos Innovadores en el Tratamiento de Enfermedades Neurodegenerativas
Optimisation and Pre-Validation of an In Vitro Test Strategy for Predicting Human Acute Toxicity
92
Nuria Campillo

Científico titular

Biología Físico-Química

Centro de Investigaciones Biológicas (CIB-CSIC)

Madrid, España

29
Ana Martinez

Research Professor

Centro Investigaciones Biológicas (CIB)

Consejo Superior de Investigaciones Científicas (CSIC)

Madrid, Chile

1
Jimena Cuenca

Investigador/profesor

Facultad de Medicina

Universidad de Los Andes

Santiago, Chile